CONFOMETRX, INC.
ClosedCommitted to Excellence in Innovation
Palo Alto, United States · Founded 2015 · $33.5M raised
- Headquarters
- Palo Alto, California
- Founded
- 2015
- Business Model
- B2B
- Website
- confometrx.com
- Total Funding
- $33.5M
- Last Round
- $33.5M Series AJan 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
ConfometRx is a pioneer in G protein-coupled receptor (GPCR) structural characterization and GPCR-targeted drug discovery, leveraging over a decade of proprietary protein engineering expertise. The company uses X-ray crystallography and cryo-EM to elucidate GPCR structures, then screens small-molecule libraries to identify therapeutic candidates for CNS, respiratory, and metabolic diseases. Co-founded by Nobel Prize laureate Dr. Brian Kobilka of Stanford University.
Summary
CONFOMETRX, INC. is a Biotech company based in Palo Alto, United States, founded in 2015. It has raised $33.5M in total across 1 round, most recently a $33.5M Series A round in Jan 2024. Investors include BioGeneration Ventures, Wellington Management and Fund+.
Funding History
2024 (est.)
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/confometrx-inc"><img src="https://indexed.vc/api/badge/company/confometrx-inc" alt="CONFOMETRX, INC. on Indexed.vc" width="260" height="76" /></a>